Scattering Amplitudes and BCFW Recursion in Twistor Space

Twistor ideas have led to a number of recent advances in our understanding of scattering amplitudes. Much of this work has been indirect, determining the twistor space support of scattering amplitudes by examining the amplitudes in momentum space. In this paper, we construct the actual twistor scattering amplitudes themselves. We show that the recursion relations of Britto, Cachazo, Feng and Witten have a natural twistor formulation that, together with the three-point seed amplitudes, allows us to recursively construct general tree amplitudes in twistor space. We obtain explicit formulae for $n$-particle MHV and NMHV super-amplitudes, their CPT conjugates (whose representations are distinct in our chiral framework), and the eight particle N^2MHV super-amplitude. We also give simple closed form formulae for the N=8 supergravity recursion and the MHV and conjugate MHV amplitudes. This gives a formulation of scattering amplitudes in maximally supersymmetric theories in which superconformal symmetry and its breaking is manifest. For N^kMHV, the amplitudes are given by 2n-4 integrals in the form of Hilbert transforms of a product of $n-k-2$ purely geometric, superconformally invariant twistor delta functions, dressed by certain sign operators. These sign operators subtly violate conformal invariance, even for tree-level amplitudes in N=4 super Yang-Mills, and we trace their origin to a topological property of split signature space-time. We develop the twistor transform to relate our work to the ambidextrous twistor diagram approach of Hodges and of Arkani-Hamed, Cachazo, Cheung and Kaplan.Comment: v2: minor corrections + extra refs. v3: further minor corrections, extra discussion of signature issues + more ref

Stimulant Reduction Intervention using Dosed Exercise (STRIDE) - CTN 0037: Study protocol for a randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>There is a need for novel approaches to the treatment of stimulant abuse and dependence. Clinical data examining the use of exercise as a treatment for the abuse of nicotine, alcohol, and other substances suggest that exercise may be a beneficial treatment for stimulant abuse, with direct effects on decreased use and craving. In addition, exercise has the potential to improve other health domains that may be adversely affected by stimulant use or its treatment, such as sleep disturbance, cognitive function, mood, weight gain, quality of life, and anhedonia, since it has been shown to improve many of these domains in a number of other clinical disorders. Furthermore, neurobiological evidence provides plausible mechanisms by which exercise could positively affect treatment outcomes. The current manuscript presents the rationale, design considerations, and study design of the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN) CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) study.</p> <p>Methods/Design</p> <p>STRIDE is a multisite randomized clinical trial that compares exercise to health education as potential treatments for stimulant abuse or dependence. This study will evaluate individuals diagnosed with stimulant abuse or dependence who are receiving treatment in a residential setting. Three hundred and thirty eligible and interested participants who provide informed consent will be randomized to one of two treatment arms: Vigorous Intensity High Dose Exercise Augmentation (DEI) or Health Education Intervention Augmentation (HEI). Both groups will receive TAU (i.e., usual care). The treatment arms are structured such that the quantity of visits is similar to allow for equivalent contact between groups. In both arms, participants will begin with supervised sessions 3 times per week during the 12-week acute phase of the study. Supervised sessions will be conducted as one-on-one (i.e., individual) sessions, although other participants may be exercising at the same time. Following the 12-week acute phase, participants will begin a 6-month continuation phase during which time they will attend one weekly supervised DEI or HEI session.</p> <p>Clinical Trials Registry</p> <p>ClinicalTrials.gov, <a href="http://www.clinicaltrials.gov/ct2/show/NCT01141608">NCT01141608</a></p> <p><url>http://clinicaltrials.gov/ct2/show/NCT01141608?term=Stimulant+Reduction+Intervention+using+Dosed+Exercise&rank=1</url></p

AOB community structure and richness under European beech, sessile oak, Norway spruce and Douglas-fir at three temperate forest sites

Abstract Background and aims The relations between tree species, microbial diversity and activity can alter ecosystem functioning. We investigated ammonia oxidizing bacteria (AOB) community structure and richness, microbial/environmental factors related to AOB diversity and the relationship between AOB diversity and the nitrification process under several tree species. Methods Forest floor (Of, Oh) was sampled under European beech, sessile oak, Norway spruce and Douglas-fir at three sites. AOB community structure was assessed by PCR-DGGE and sequencing. Samples were analyzed for net N mineralization, potential nitrification, basal respiration, microbial biomass, microbial or metabolic quotient, pH, total nitrogen, extractable ammonium, organic matter content and exchangeable cations. Results AOB community structure and tree species effect on AOB diversity were site-specific. AOB richness was not related to nitrification. Factors regulating ammonium availability, i.e. net N mineralization or microbial biomass, were related to AOB community structure. Conclusion Our research shows that, at larger spatial scales, site specific characteristics may be more important than the nature of tree species in determining AOB diversity (richness and community structure). Within sites, tree species influence AOB diversity. The absence of a relation between AOB richness and nitrification points to a possibly role of AOB abundance, phenotypic plasticity or the implication of ammonia oxidizing archaea